Creative Commons source reading · Team and collective performance
Prebiotic Bimuno® GOS reduces illness symptoms and supports gut barrier function and immunity after intermittent exercise in the heat
Connor J. Parker; Samantha J. Abbott; Luke R. Butterfield; Kirsty A. Hunter; Michael A. Johnson; Graham R. Sharpe; Neil C. Williams
Originally published in Exp Physiol · 2026-03-24
From the article
Selected source text. JournalOS removes markup and shortens excerpts where indicated. The full article provides the complete context.
Abstract
AbstractExercise in hot climates increases the risk of gastrointestinal (GI) disruption and respiratory illness. We investigated the effects of a 42 day prebiotic intervention on markers of intestinal epithelial injury, GI discomfort and immunity following football specific exercise in the heat and daily upper respiratory illness. Twenty‐six team‐sport male athletes were randomized to receive 3.65 (2.75 active galactooligosaccharide) g day−1 of either Bimuno galactooligosaccharide (Bimuno® GOS; n = 13) or a maltodextrin placebo (Placebo; n = 13) for 42 days in a double‐blind parallel group design. At days 0 and 42 of each intervention, participants completed the football specific intermittent treadmill protocol in 33°C and 50% relative humidity. Blood, saliva and GI symptoms were collected at days 0 and 42 for the assessment of plasma…
DISCUSSION
The aim of the present study was to evaluate the effects of a 42 day prebiotic (Bimuno® GOS) intervention on GIS, circulatory markers of intestinal epithelial injury and permeability, and immunity during a simulated football activity in the heat, whilst also assessing URS and GIS over the intervention period. The present study is thought to be the first to demonstrate that 42 days of the daily prebiotic Bimuno® GOS (2.75 g day−1 active GOS) can attenuate the increase in circulating I‐FABP after football‐based exercise in the heat, suggestive of improved gut barrier integrity, whilst lowering exercise‐induced GIS severity. Furthermore, 42 days of Bimuno® GOS reduced resting GIS severity. Finally, those supplemented with Bimuno® GOS experienced shorter and less severe URS episodes during the intervention period, and there was a greater…
CONCLUSION
In conclusion, a 42 day supplementation with prebiotic Bimuno® GOS reduced exercise‐induced GI damage and GIS during a simulated football match in the heat. This was accompanied by a greater maintenance of sIgA immediately postexercise. In accordance with previous literature, Bimuno® GOS also reduced URS severity and duration in addition to GIS during the supplementation period. These findings suggest that prebiotic Bimuno® GOS might have the potential to enhance GI barrier integrity during exercise, modulate immune function and reduce the burden of acute respiratory illness and GI symptoms, which might improve athlete availability. Future research should explore the possible underpinning mechanisms of Bimuno® GOS on the alleviation of illness and exercise‐induced GI damage.
Editorial reading guide
- At what level—athlete, team, organization or system—was the evidence collected?
- Which actors control the decision, and which measures reveal unintended consequences?
